Association of autoimmunity and long-term complete remission in patients with Sezary syndrome treated with mogamulizumab

被引：31
作者：
Bonnet, P. [1 ]
Battistella, M. [2 ]
Roelens, M. [3 ]
Ram-Wolff, C. [1 ]
Herms, F. [1 ]
Frumholtz, L. [1 ]
Bouaziz, J. -D. [1 ]
Brice, P. [4 ]
Moins-Teisserenc, H. [3 ]
Bagot, M. [1 ]
de Masson, A. [1 ]
机构：
[1] Paris Diderot Univ, St Louis Hosp, Dept Dermatol, INSERM,U976, 1 Ave Claude Vellefaux, F-75010 Paris, France
[2] Paris Diderot Univ, St Louis Hosp, Dept Pathol, Paris, France
[3] Paris Diderot Univ, Inst Univ Hematol, Dept Immunol & Histocompatibil, INSERM,U1160, Paris, France
[4] Paris Diderot Univ, St Louis Hosp, Dept Hematooncol, Paris, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 180卷 / 02期
关键词：
MEDIATED INTERFACE DERMATITIS; DEPLETION; ANTIBODY; KW-0761;
D O I：
10.1111/bjd.17320
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 8 条
  • [1] Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration
    Hosoi, Hiroki
    Mushino, Toshiki
    Nishikawa, Akinori
    Hashimoto, Hisako
    Murata, Shogo
    Hatanaka, Kazuo
    Tamura, Shinobu
    Hanaoka, Nobuyuki
    Shimizu, Norio
    Sonoki, Takashi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (06) : 717 - 719
  • [2] Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
    Ishida, Takashi
    Joh, Tatsuro
    Uike, Naokuni
    Yamamoto, Kazuhito
    Utsunomiya, Atae
    Yoshida, Shinichiro
    Saburi, Yoshio
    Miyamoto, Toshihiro
    Takemoto, Shigeki
    Suzushima, Hitoshi
    Tsukasaki, Kunihiro
    Nosaka, Kisato
    Fujiwara, Hiroshi
    Ishitsuka, Kenji
    Inagaki, Hiroshi
    Ogura, Michinori
    Akinaga, Shiro
    Tomonaga, Masao
    Tobinai, Kensei
    Ueda, Ryuzo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 837 - 842
  • [3] CD8+ T-cell-mediated Interface Dermatitis after CCR4+ T-cell Depletion by Mogamulizumab Treatment of Adult T-cell Leukaemia/lymphoma
    Ito, Ayako
    Sugita, Kazunari
    Adachi, Koji
    Hosoda, Yuzuru
    Motokura, Toru
    Yamamoto, Osamu
    [J]. ACTA DERMATO-VENEREOLOGICA, 2017, 97 (03) : 377 - 378
  • [4] Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
    Kim, Youn H.
    Bagot, Martine
    Pinter-Brown, Lauren
    Rook, Alain H.
    Porcu, Pierluigi
    Horwitz, Steven M.
    Whittaker, Sean
    Tokura, Yoshiki
    Vermeer, Maarten
    Zinzani, Pier Luigi
    Sokol, Lubomir
    Morris, Stephen
    Kim, Ellen J.
    Ortiz-Romero, Pablo L.
    Eradat, Herbert
    Scarisbrick, Julia
    Tsianakas, Athanasios
    Elmets, Craig
    Dalle, Stephane
    Fisher, David C.
    Halwani, Ahmad
    Poligone, Brian
    Greer, John
    Fierro, Maria Teresa
    Khot, Amit
    Moskowitz, Alison J.
    Musiek, Amy
    Shustov, Andrei
    Pro, Barbara
    Geskin, Larisa J.
    Dwyer, Karen
    Moriya, Junji
    Leoni, Mollie
    Humphrey, Jeffrey S.
    Hudgens, Stacie
    Grebennik, Dmitri O.
    Tobinai, Kensei
    Duvic, Madeleine
    [J]. LANCET ONCOLOGY, 2018, 19 (09) : 1192 - 1204
  • [5] Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
    Kurose, Koji
    Ohue, Yoshihiro
    Wada, Hisashi
    Iida, Shinsuke
    Ishida, Takashi
    Kojima, Takashi
    Doi, Toshihiko
    Suzuki, Susumu
    Isobe, Midori
    Funakoshi, Takeru
    Kakimi, Kazuhiro
    Nishikawa, Hiroyoshi
    Udono, Heiichiro
    Oka, Mikio
    Ueda, Ryuzo
    Nakayama, Eiichi
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4327 - 4336
  • [6] Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma
    Shiratori, Souichi
    Ohhigashi, Hiroyuki
    Ito, Shinichi
    Kudo, Kazuhiro
    Adachi, Maki
    Minamimoto, Toshiyuki
    Kato, Junji
    Osai, Yasue
    Tsutsumi, Yutaka
    Teshima, Takanori
    [J]. HEMATOLOGICAL ONCOLOGY, 2017, 35 (01) : 138 - 140
  • [7] CD8+T cell-mediated interface dermatitis during combination chemotherapy with mogamulizumab in a patient with adult T-cell leukaemia/lymphoma
    Tani, N.
    Sugita, K.
    Ito, A.
    Ooi, S.
    Yamamoto, O.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (06) : 736 - 737
  • [8] Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma
    Tokunaga, Masahito
    Yonekura, Kentaro
    Nakamura, Daisuke
    Haraguchi, Kouichi
    Tabuchi, Tomohisa
    Fujino, Satoshi
    Hayashida, Maiko
    Maekawa, Kenichi
    Arai, Akihiko
    Nakano, Nobuaki
    Kamada, Yuhei
    Kubota, Ayumu
    Inoue, Hirosaka
    Owatari, Satsuki
    Takeuchi, Shogo
    Takatsuka, Yoshifusa
    Otsuka, Maki
    Hanada, Shuichi
    Matsumoto, Tadashi
    Yoshimitsu, Makoto
    Ishitsuka, Kenji
    Utsunomiya, Atae
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (04) : 539 - 542
1